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Summary
A growing amount of evidence shows that clinical, but also fundamental neurosci-
entific studies benefit from ultra-high field MRI (Trattnig et al., 2016; Ugurbil, 2017). 
Because of the higher SNR (Pohmann et al., 2016), 7T MRI is able to provide anatomi-
cal and functional images with great detail and contrast, without jeopardizing patient 
comfort and, hereby, outperforming field strengths that are typically used in the clinic 
(≤ 3T). As such, the imaging community is pushing ultra-high field MRI forward, which 
recently led to the CE certificate and FDA approval for the Siemens 7T Magnetom Terra 
scanner, paving the way for clinical use in Europe and North America, respectively. 
The number of research centers that operate 7T MRI scanners has steadily increased 
in the last years and has led to tremendous improvements in hardware, instrumenta-
tion and sequence design (Ugurbil, 2017; Polimeni and Uludağ, 2018). Consequential-
ly, it becomes possible to acquire high quality, high resolution, multi-parametric data 
within an hour. Depending on the specific research aims and/or study population, 
several choices have to be made for the design of the imaging protocol: (i) weighted 
or quantitative imaging (not mutually exclusive), (ii) type of contrasts (e.g. T1, T2
(*), 
MT, perfusion, diffusion, fMRI), (iii) spatial (and temporal) resolution and (iv) spatial 
coverage (Marques and Norris, 2017). Throughout the current thesis, we explored the 
different properties and applications of a multi-parameter, quantitative protocol in 
healthy subjects and in metabolic diseases. This protocol was developed to capture 
the biochemical (i.e. microstructure) and metabolic (i.e. blood flow) properties of the 
brain. In this chapter, we first briefly summarize the work presented in this thesis, 
followed by a discussion on several related issues and developments that are central to 
consider for a more broad use of the protocol. Finally, we conclude with a description 
of a potential application and work in progress not explored in this thesis. 
6.1. | SUMMARY
The MP2RAGE sequence is widely used for anatomical imaging at 7T (Marques et al., 
2010). Initially developed on the Siemens system platform, it has also been extended 
towards other 7T vendors (Mougin et al., 2016). In addition to the standard acquisition 
of a T1w image, a quantitative T1 map is obtained in this approach, allowing studying 
brain microstructure besides morphology. However, B1
+-related image artifacts – too 
strong to correct by using dielectric pads (Teeuwisse et al., 2012) and specialized 
adiabatic inversion pulses (Hurley et al., 2010) – hamper accurate analyses in the 
affected regions. Especially brain regions that suffer from severe local field inhomoge-
neity effects, such as the inferior temporal and frontal lobes, are difficult to properly 
segment into white (WM), gray matter (GM) and cerebrospinal fluid (CSF). As a result, 
tedious manual corrections of the automatic image segmentations are necessary to 
170
CHAPTER 6 
correct for these errors and causes excessive amounts of work, in particular in large-
scale imaging studies. Therefore, in Chapter 2, we explored the benefits on cortical 
thickness measurements and T1(w) contrast when the B1
+-related variations across the 
cortex are taken into account using the Sa2RAGE B1
+ map. By doing so, substantial im-
provement in the delineation between WM, GM and CSF could be achieved due to the 
locally improved contrast between tissue types. This resulted in more accurate cortical 
thickness measurements, shown by the increased correspondence with a normative 
dataset. In addition, we showed that the cortical T1 values were significantly biased 
by the non-uniform RF transmit efficiency prior to the post-hoc B1+ correction, leading 
to artificially increased variation across the cortex. The latter phenomenon was sig-
nificantly reduced after the correction, revealing the typical myelin-related pattern 
observed in earlier and lower field strength studies (Glasser and Van Essen, 2011; Lutti 
et al., 2014). Similar improvements (e.g. increased inter-tissue type contrast) has also 
been shown for the subcortical GM structures (Marques and Gruetter, 2013). Taken 
together, these results have important implications for future studies that use the 
MP2RAGE data for morphological and/or microstructural analyses. Similar biases are 
also expected for other T1 acquisition approaches (e.g. also in the standard T1w images 
using MPRAGE, the WM/GM contrast is low in the anterior temporal lobe). Finally, 
supported by its easy implementation and short scanning duration, this correction 
step should be part of any users’ MP2RAGE data pre-processing workflow.
Following up on the work from the previous chapter to obtain more accurate surface 
reconstructions of the brain, Chapter 3 compares the performance of several popular 
myelin-based mapping approaches using anatomical 7T data. Here, reproducibili-
ty and reliability of weighted and quantitative T1 (i.e. corrected for the B1
+ bias field, 
explained above), T2* and their ratio were compared in terms of contrast-to-noise ratio 
(CNR), parcellation reliability (i.e. ‘parcellability’), and inter- and intra-subject variability 
and reproducibility. Quantitative MRI methods are considered more robust compared 
to their weighted counterparts in terms of non-biochemical influences, due to their 
dominant dependence on intrinsic tissue properties, such as longitudinal (T1) or trans-
versal relaxation times (T2*). In contrast, weighted imaging is additionally affected by 
non-biochemical factors, such as sensitivity to MRI acquisition parameters and image 
imperfections (e.g. B0 and B1 inhomogeneities). As such, quantitative MRI allows more 
reliable and biology-relevant comparisons within subjects and between healthy 
subjects and patients. However, while both types of contrasts (i.e. quantitative vs. 
weighted) may be appropriate to accurately capture the variation of myelin and iron 
concentration across the cortex within a subject (but not necessarily across subjects), 
they were previously not systematically compared at 7T. In our study, similar but not 
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identical myelination patterns were observed across all tested contrasts. However, we 
found that CNR per unit time and parcellability were lower for the transversal compared 
to the longitudinal relaxation parameters. In addition, quantitative R1 (=1/T1) turned 
out to be the most reliable parameter to map the myelin distribution compared to the 
other parameters. The respective maps were characterized by the lowest inter- and in-
tra-subject coefficient of variation. In addition, these spatial surface maps can be used 
for microstructure-informed delineation of cortical areas. We explored two area-de-
fining methods: (i) thresholding the MR parameter values and (ii) surface gradients of 
these values, to determine areal borders based on the cortical surface pattern. Both 
methods are partially observer-dependent, needing manual interaction (i.e., choice 
of threshold or connecting high gradient values) to provide unambiguous borders. In 
order to obtain fully data-driven cortical parcellations and to overcome this observ-
er-dependency, several methods have been developed in this emerging field. We will 
briefly discuss this topic later in this chapter and show some examples. 
Similar to the studies presented in Chapters 2 and 3, we acquired quantitative MRI 
data, additionally including cerebral blood flow (CBF), in metabolic diseases. Here, 
the MRI data were combined with genetic analyses in order to relate morphological-, 
microstructural- and metabolic-related variations in the brain, measured using MRI, 
to genetic differences across the study population (i.e. ‘imaging genetics’). This was 
performed in a metabolic disease, for which the genetic underpinning is well estab-
lished and only the mutation load varies between patients (Chapter 4) and in Type 
2 Diabetes Mellitus (T2DM), a more complex polygenetic disorder (Chapter 5). In 
Chapter 4, we examined patients with m.3243A>G mutation; this mutation affects 
the mitochondrial DNA and leads to the expression of a widely varying phenotype 
across the patient population. Symptoms often observed include hearing loss, devel-
opment of (mitochondrial) diabetes, muscle atrophy, as well as tissue changes in the 
brain. Interestingly, the number of mutated mitochondria in a single cell, referred to as 
‘mutation load’, differs across tissue types (i.e. blood and urine epithelial cells), but also 
between patients. Previous studies have shown that the disease severity positively 
correlates with the mutation load measured across several tissue types. However, none 
of them investigated potential brain correlates. Therefore, the aim of the small-scale 
imaging genetics study was to assess to this relation using the mutation load in blood 
and urine. In our patient population, the mutation loads in blood and urine significant-
ly correlated with disease severity, confirming the observations in earlier studies. We 
found a strong correlation between brain volume and both mutation loads, however, 
more strongly for that measured in blood. Cortical GM, WM and cerebellar GM volume 
significantly decreased with increasing mutation load. Interestingly, subcortical GM 
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(i.e. putamen and globus pallidus) volume was lower for the m.3243A>G patients 
compared to controls, but no mutation load effect was observed. In addition, clusters 
of vertices were identified, where cortical thickness significantly decreased, while T1, T2* 
and CBF tend to increase as function of mutation load. These clusters spanned specific 
areas involved in auditory processing (e.g. auditory cortex) and those that are charac-
terized by a higher resting-state connectivity (e.g. default-mode and default-attention 
networks). These observations can be linked to the clinical symptoms in m.3243A>G 
patients, such as hearing loss and decreased attentional/executive functioning. These 
results may guide future MRI, but also in vitro, studies to track disease pathogenesis 
and relationship with specific clinical symptoms.
While the work and analyses in Chapter 4 are straightforward, the population and 
analysis strategies presented in Chapter 5 are more challenging. In this chapter, the 
main focus was to highlight the different types of data and discuss potential analyses 
strategies, in addition to providing a brief description of the preliminary output from 
the proposed analyses workflows. The clinical characteristics of the study popula-
tion confirmed the significant differences in the cardiovascular profiles (e.g. blood 
glucose and lipid levels) across groups, which was expected based on the group-spe-
cific inclusion criteria. Ultimately, the data will be analyzed from different perspectives 
with the aim to develop multi-level biomarkers in metabolic syndrome (MetS) and 
T2DM. Due to the complex genetic nature of T2DM, the high dimensionality of the 
data, and the possibility to merge multiple data modalities (i.e. MRI, genetic, metab-
olomic, cognitive and clinical), more advanced statistical methods have to be utilized 
to identify T2DM biomarkers. For this, the availability of each dataset can be used to 
good advantage. For example, we showed a cluster of metabolites that were present 
in distinct quantities in T2DM subjects compared to controls. Therefore, characteri-
zation of the related metabolic pathways, based on this data, may provide clues for 
narrowing down analyses, and formulation of specific hypotheses with regards to the 
whole-exome sequencing data.
While interesting from an imaging genetics or ‘imaging -omics’ point of view, the 
presented dataset also provides opportunities to explore each data modality separate-
ly. Genotype-phenotype relationships, as well as metabolomic profiles, can be estab-
lished to define modality-specific biomarkers that potentially might aid the explana-
tion of phenotypical and functional differences across subjects/groups. However, the 
sample size (N=133) – even though high for a 7T study – is rather limited for genetic 
and metabolomic studies, for which sample sizes of >1000 are preferred. Dimen-
sionality reduction/feature selection (i.e. filtering) techniques, such as independent 
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component analysis, but also methods using prior knowledge (Kircher et al., 2014), 
become more important (Saeys et al., 2007). This is less crucial for the MRI part, as it 
represents a rich and unique dataset that can be used to answer several modality-spe-
cific research questions. For example, the submillimeter resolution of the anatomical 
data provides spatial details that can be used to identify small-scale structural changes 
in the brain as a result of impaired glucose metabolism. This includes changes in tissue 
susceptibility due to cerebral microbleeds or iron depositions. Also more methodolog-
ically relevant questions can be answered, such as the relationship between blood T1 
and hematocrit levels and how this changes in T2DM, an issue important for the quan-
tification of cerebral blood flow using ASL (Xu et al., 2018). Across all applications of 7T 
MRI described in this thesis, it is important to monitor and evaluate data quality, crucial 
for implementing these approaches in clinical populations. Therefore, in the following, 
we will address some of the issues encountered for the different imaging contrasts and 
describe potential technological developments that may be able to overcome these.
6.2. | STANDARDIZATION AND HARMONIZATION OF CLINICAL  
QUANTITATIVE 7T MRI 
It has been highlighted throughout this thesis that 7T imaging provides a number of 
advantages compared to lower field strengths. In addition, the presented data demon-
strates the possibility to acquire whole-brain high resolution anatomical, perfusion 
and functional data within an hour and its application to study neurodegeneration in 
a clinical population. However, the potential of 7T reaches far beyond what is demon-
strated in this thesis, including fMRI (Uludag and Blinder, 2017), spectroscopy (Bogner 
et al., 2011), diffusion (Vu et al., 2015) and vascular imaging (De Cocker et al., 2016). The 
addition of such measurements will complement our protocol and boosts the range of 
applications it can be used for. Quality assessment, standardization and harmonization 
of MRI protocols are essential in order to allow utilization and generalization of such 
protocols across studies, imaging sites and scanner vendors. 
Acquisition of large-scale datasets, too expensive to cover by individual institutions, 
as well as those in rare diseases, such as in m.3243A>G patients, can be promoted due 
to the possibilities to pool data across multiple imaging sites. Several nation-wide and 
international 7T networks have been established to serve this purpose, such as the 
German Ultra High Field Imaging (GUFI) and United Kingdom’s 7T (UK7T) networks and 
European Ultra-high field Imaging Network for Neurodegenerative Diseases (EUFIND). 
These consortia aim to set up standardized sequences across the main 7T suppliers 
that limit the effect of hard- (e.g. coils and gradients) and software (e.g. imaging 
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sequence implementations and reconstruction methods) differences. Sequences and 
corresponding parameters need to be chosen in such a way that they are applicable 
across Siemens, Philips and General Electric (GE) systems and provide comparable 
data in terms of temporal and spatial SNR and CNR. Here, it is important to find the 
right balance between conformity across vendors and maximal performances within 
vendor (i.e. not necessarily accepting a ‘least common denominator’ solution). The 
generalizability of clinical MRI depends on the comparability of the data generated at 
different sites, scanner vendors and time points (Voelker et al., 2016). Quantitative MRI 
(ideally) overcomes potential, non-biochemical inter-site, intra-subject biases that are 
present in weighted MRI data, which hinder the direct comparison across studies and 
between patients and healthy controls. Hereafter, we will address some of the quali-
ty-related issues that were encountered while acquiring and analyzing the presented 
data.
6.2.1. | Anatomical imaging
The results in Chapters 2 and 3 demonstrated that the quality of anatomical data 
acquired at 7T depends on the type of contrast. Here, quantitative T1 maps were more 
robust across subjects and within subjects, compared to their weighted counterparts. 
However, in order to obtain more precise T1 maps, we show that homogeneous RF 
transmit profiles are important, even for quantitative data. To limit possible con-
founding effects due to this, sequence (i.e. MP2RAGE, in this case) parameters can be 
optimized in such a way that the B1
+ dependency is decreased or, alternatively, CNR 
is increased, depending on the specific study aim (Marques and Gruetter, 2013). In 
contrast, quantitative T2* maps were characterized by a much higher variation and 
sensitivity for non-biochemical variation, in line with previous findings at lower field 
strengths (Weiskopf et al., 2013). This lower reproducibility can be partly ascribed to 
susceptibility artifacts near the inferior temporal and frontal regions. Although lower 
in high resolution data, due to smaller intra-voxel spin phase coherence loss, also 
SNR differences across echo times may lead to noise enhancement when fitting the 
T2*-weighted data. Inclusion of more echo times, and potentially, a longer maximal 
echo time may improve the precision of the T2* maps, at the cost of prolonging ac-
quisition times (Cohen-Adad, 2014; Govindarajan et al., 2015). This would additionally 
enable the use of more advanced (i.e. mono-exponential vs. multi-exponential) fitting 
models to gain quantification accuracy and biochemical specificity (van Gelderen et 
al., 2012). Alternatively, T2 (i.e. transversal relaxation time for spin-echo sequences, less 
affected by local field inhomogeneities), instead of T2*, imaging, may yield more re-
producible data. However, as for now, acquisition of whole-brain T2-weighted images 
at 7T remains challenging due to inhomogeneous transmit profiles, power deposition 
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limitations and long acquisition times using conventional single-channel transmis-
sion. In addition, T2* maps may be more biochemically informative, due to its higher 
dependency on local changes in iron concentration (Cohen-Adad, 2014; Stuber et al., 
2014). 
6.2.2. | Perfusion imaging
While anatomical and functional imaging at 7T benefit from ultra-high field strengths, 
this is less evident for ASL imaging. Compared to the T1 and T2* maps, ASL data presum-
ably harbors lower SNR and CNR. Although improvements were observed compared to 
lower fields strengths, in particular at higher spatial resolutions (Gardener et al., 2009; 
Ivanov et al., 2017), ASL suffers from persisting problems (Teeuwisse et al., 2010). The 
upper limit of ASL SNR is determined by the low GM microvascular density (~1%–2% 
of local tissue volume) and signal reduction due to T1 recovery after labeling. Espe-
cially for clinical purposes, when scanning time is a limiting factor, increasing the SNR 
is challenging. In addition, acquisition of whole-brain CBF maps remains an issue, as 
well as the sensitivity of CBF acquisitions to subject motion. Several possible practical 
solutions have been explored to maximize data quality. These include, for example, the 
use of dielectric pads, and optimized positioning of the head and magnet isocenter 
reference to improve to B1
+ homogeneity and labeling efficiency, respectively (Ghariq 
et al., 2012). Also, several improvements in sequence design have been proposed to 
increase coverage without increasing scan time. This includes the implementation of 
echo-planar imaging (EPI) readouts, parallel (e.g. generalized autocalibrating partially 
parallel acquisitions, GRAPPA), simultaneous multi-slice (SMS, which also reduces 
motion sensitivity) or multi-band (MB) imaging (Feinberg et al., 2013; Kim et al., 2013; 
Ivanov et al., 2017). While these methods may lead to losses in (temporal) SNR, the 
sequence parameters in the current protocol were chosen such that the loss in (t)SNR 
was kept minimal for maximal brain coverage (~80%) (see also Ivanov et al. (2017) 
and references herein for more details and an in-depth discussion of ASL at UHF). To 
conclude, ASL is a promising tool to measure brain perfusion non-invasively; however, 
future studies and technical developments (see below) are necessary to reach its full 
potential at UHF.
6.3. | TECHNICAL DEVELOPMENTS TO IMPROVE CLINICAL  
APPLICABILITY OF 7T
Several technical developments are currently being explored to improve the clinical 
applicability of 7T imaging and to overcome (some of ) the limitations described above. 
This includes, for example, prospective motion correction. Prospective motion correc-
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tion can be used for real-time updating of most pulse sequences to reduce artifacts 
caused by head motion and therefore it has potential to make a large impact in clinical 
routine (Maclaren et al., 2013). In addition, magnetic field monitoring, to compen-
sate for spatiotemporal field perturbations, is another promising technique to reduce 
image artifacts and distortion (Barmet et al., 2008). Field control improved the fidelity 
of T2* maps by mitigating field changes related to the subject’s breathing pattern, for 
example (Wyss et al., 2017). 
The introduction of the parallel (i.e. multi-channel) transmission (pTx) technology has 
been one of the main developments for UHF imaging. It may resolve some, if not many, 
of the issues discussed above, by improving the temporal resolution and energy effi-
ciency of the radio-frequency (RF) pulses (Katscher et al., 2003; Zhu, 2004). Advanced 
coil designs (Shajan et al., 2014; Sengupta et al., 2016) and RF pulses (Setsompop et al., 
2008; Poser et al., 2014) are being developed to take full advantage of the technology. 
Shorter excitations can be achieved without risking data quality reduction, which is 
particularly beneficial for clinical purposes. Alternatively, it can be used to reduce B1+ 
inhomogeneities and resulting image contrast biases across and within subjects (such 
as observed in Chapters 2 and 3) and imaging sites, without increasing scan duration 
(Cloos et al., 2012). In addition, ASL techniques will benefit from parallel transmission 
by enabling a more tailored labeling field maximizing labeling efficiency (Oliver-Taylor 
et al., 2012). So far, the majority of current pTx-related studies depended mostly on 
custom hard- (e.g. coils) and software (e.g. sequences) not publicly available and only 
little work has been transferred into clinical practice, although clinical applications of 
dual-transmit systems have been discussed (Brink et al., 2015). Future work is necessary 
to further assess the advantages of pTx and improve its workflow for clinical routine, 
for example, by limiting the required user interaction and computational complexity.
 
6.4. | CLINICAL INTERPRETATION OF QUANTITATIVE 7T MRI 
Given the increased spatial resolution and contrast that can be obtained using (quanti-
tative) 7T MRI, better understanding of the biophysical mechanisms and their relation 
to pathologies, are necessary to improve clinical decision-making. This requires inter-
disciplinary research to link, for example, changes in tissue composition (e.g. studied 
by biologists and chemists), due to disease (e.g. pathologists), to differences of the 
measured MRI signal (e.g. physicists) and specialized data analysis methods (i.e. data 
scientists), eventually. As such, optimization of quantitative MRI – based on a single 
or multiple MR parameter(s) – is vital to better reflect the underlying tissue properties 
and dynamics of biological processes, including changes in the homeostasis of mac-
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romolecular compounds due to disease. Here, because of their clinical relevance in, 
for example, Parkinson’s (PD) and Alzheimer’s Disease (AD), iron and neuromelanin, 
have been one of the main targets of such interdisciplinary research (Keren et al., 2015; 
Bulk et al., 2018). As a result of histological and biochemical validation studies, MRI 
sequences can be optimized to better image and characterize brain structures in vivo, 
due to an improved understanding of their biochemical composition (Priovoulos et al., 
2017; Ropele and Langkammer, 2017). Obviously, these methods can also be extended 
towards other clinical phenotypes, including optimized detection of microbleeds and 
iron depositions in T2DM subjects. Finally, machine-learning methods that target 
these features, may facilitate diagnosis and prognosis by a clinician.
6.5. | MULTI-PARAMETER, QUANTITATIVE MRI-BASED CORTICAL  
PARCELLATION
Despite the many advantages of acquiring high-resolution data, continuous develop-
ments and prospects for clinical use, its high dimensionality and resulting low statis-
tical power (especially in whole-brain studies), necessitates the improvement of data 
analysis methods as well. As discussed in Chapter 5, the brain phenotype dimension-
ality can be reduced using parcellation techniques. By this means, data complexity 
is decreased while statistical power is increased. Automatic segmentation software 
packages, such as FreeSurfer, typically use macro-anatomical (gyral and sulcal) 
landmarks and/or predefined atlases to subdivide the (sub-)cortical GM into distinct 
regions (Fischl et al., 2004; Desikan et al., 2006). More and more, the focus of MRI-data 
based cortical parcellation is shifting towards individualized methods based on in vivo 
morphological (i.e. cortical thickness), microstructural (i.e. T1 and T2*) or anatomical (i.e. 
DTI) and functional (i.e. task- or rs-fMRI) connectivity derivates (Geyer et al., 2011; Yeo 
et al., 2011; Ganepola et al., 2017). 
One of the most important advances in this field was the release of a cortical parcel-
lation map based on multiple modalities, including cortical thickness, myelin content 
(i.e. T1/T2 ratio) and (task- and resting state-based) functional 3T data from the Human 
Connectome Project (Glasser et al., 2016). Here, a gradient-based parcellation approach 
was applied to identify areal borders using predefined criteria. These criteria were 
(i) consistency across modalities, (ii) left-right symmetry, (iii) imaging artifacts inde-
pendency, (iv) strong statistical differences of modalities across opposite sides of the 
border and (v) correspondence with published boundary. After identification of the 
areas on the group-level, machine-learning algorithms were applied to automatically 
classify/label each region based on the multi-modal fingerprint on an individual basis 
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in a separate dataset. While the classifier nicely replicated the cortical parcellation 
across datasets, demonstrating its robustness, it was derived from partially manual 
procedure used by two neuroanatomists to cross-check and eventually to modify au-
tomatically determined areal borders. 
In Chapter 3, we applied the same method (i.e. computation of gradients) on the T1 
and T2* surface maps. Small differences, for example close to the auditory cortex, were 
noticeable between T1 and T2*-based boundaries across the cortex. This confirms that 
the T1 and T2* contrasts are not redundant and provide complimentary information. 
However, the borders varied in quality depending on the parameter and were not 
continuous, therefore demanding observer input when comparing parameters (i.e., 
a choice of the gradient threshold value and filling-in gaps in the borders). As such, 
other studies have explored ways to obtain fully-automatic, data-driven cortical par-
cellations, based on, for example, clustering techniques. Methods to perform such op-
erations at the single-subject or group-based level, using a single modality (i.e. fMRI) 
instead, have been recently systematically compared (Arslan et al., 2017). They show 
that, from the tested methods, none of them outperformed the others. Prioritization 
of the evaluated method characteristics (e.g. reproducibility, cluster validity or other) 
may guide the method of choice. In addition, other factors to consider are the: (i) 
single-subject and group-based performance and possibility to include (ii) multiple 
contrasts and (iii) spatial constraints.   
While none of the previous studies in the field of cortical parcellation explored the 
use of CBF, the 7T data presented in this thesis provides excellent opportunities to 
explore the benefits of including additional information based on the brain’s baseline 
perfusion (i.e. CBF). Since CBF is closely coupled to brain metabolism (Raichle, 1998), 
a data-driven parcellation of brain regions that incorporates perfusion information 
will presumably enhance subsequent functional analysis. Previous studies demon-
strated that perfusion could be used to differentiate primary from secondary auditory 
and visual areas due to a higher vascular density and metabolic demands (Weber et 
al., 2008; Gardumi et al., 2017). Preliminary analyses using current data showed that 
the effect of CBF inclusion is different across sets of regions, presumably related to 
the differences in baseline brain metabolism across the brain (Haast et al., 2017). The 
CBF data exhibited a spatial pattern different from T1, T2* and cortical thickness, e.g. 
similar higher perfusion can be clearly observed in the occipital lobe and posterior 
cingulate cortex, while T1 displays differences between these two areas. It should be 
noted, however, that the CBF data were acquired with a lower spatial resolution, and 
therefore, has lower spatial specificity. As these results are promising, we are currently 
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extending this towards a fully automatic single-subject and/or group-based cortical 
parcellation routine, using hierarchical clustering that is driven by multiple parame-
ters.
Hierarchical clustering aims to identify voxels or vertices with comparable char-
acteristics based on single or multiple contrasts (Thirion et al., 2014). In addition, 
spatial constraints can be imposed on the clustering, leading to clusters containing 
connected voxels or vertices only. As such, clusters are only formed from parents that 
share neighboring voxels/vertices based on a predefined connectivity matrix. Fig. 6.1 
shows an example group-average (N=15) cortical parcellation (Nregions=180) based on 
surface maps computed from the quantitative T1, T2*, CBF and cortical thickness data 
presented in Chapter 4 (control subjects). We used the spatially-constrained Ward’s 
hierarchical clustering algorithm implemented in the SciKit-learn toolbox (Ward Jr, 
1963; Pedregosa et al., 2011). In particular, Ward’s algorithm is very efficient in process-
ing high-dimensional MRI data. This preliminary multi-parameter cortical parcellation, 
for example, divides the cingulate cortex into separate regions and also reveals the 
typically shape of the motor cortex. 
However, in contrast to the gradients-based method, hierarchical clustering requires 
the number of clusters to be pre-defined. In the example above, we selected the 
same number of regions found in the paper by Glasser et al. (2016). Several methods 
can be used to find the optimal number of clusters based on the available data. This 
includes, for example, the Silhouette index, which scores the (data-wise) closeness of 
each vertex in one cluster to vertices in the neighboring clusters (Rousseeuw, 1987). In 
addition, bootstrap metrices to evaluate clustering consistency (e.g. adjusted mutual 
index or adjusted rand index) or cross-validation procedures may be appropriate to 
find the optimal number of clusters or test the effect of CBF on the cortical parcel-
Fig. 6.1. | Multi-parameter cortical parcellation. Quantitative cortical thickness, T1, T2* and CBF data 
from 15 subjects were used to parcellate the cortical GM into separate regions (Nregions=180). Please 
note that the inferior temporal gyrus is masked out as it suffers from strong susceptibility-related 
artifacts.
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lation (Thirion et al., 2014). However, 
the problem of number of parcels op-
timization remains open and should 
be addressed in a data-driven fashion, 
including simulations. We are currently 
characterizing, using simulations, the 
behavior of several methods that aim 
at identifying the optimal number 
of clusters. Here, we generate spatial 
2D patterns, representing a single 
parameter, with a known ground truth 
(i.e. number of clusters) and varying 
levels of noise. This can be extended to 
multi-parametric data with correspond-
ing levels of noise (i.e. mimicking the intensity range and quality of cortical thickness, 
T1, T2* and CBF maps) and to patterns more closely resembling the brain’s structure. 
For example, Fig. 6.2 shows the Silhouette scores for clustering performance across a 
range of Nclusters (i.e. 1 suggests optimal cluster separation), based on simulated single 
parameter data with varying noise and a known ground truth (Nclusters = 9). Here, the 
same clustering method was used as for the example in Fig. 6.1, using Ward’s criteria 
and connectivity constraints and shows that performance of the Silhouette score 
decreases with increasing noise levels. Finally, extending this work towards the larger 
dataset described in Chapter 5 can address its reproducibility/stability across multiple 
datasets, as well as identify regions that are most distinct between controls and T2DM 
or correlate with specific cognitive scores, which are expected to be found mostly in 
the frontal and temporal lobe.
6.6. | CONCLUSION
Taken together, the work in this thesis demonstrated possible applications of a 
standard quantitative brain 7T MRI protocol. The possibilities of 7T MRI are far-reach-
ing and need continuous developments, ranging from development of hardware to 
Fig. 6.2. | Evaluation of the Silhouette score for 
finding the optimal number of clusters using 
simulated data with varying levels of noise. As 
can be observed and as expected, the perfor-
mance of the Silhouette score (i.e. 1 suggests 
optimal delineation between areas) decreases 
with increasing noise levels.
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analysis software, that enable acquisition of high quality data and processing this data 
in the most optimal way. The current work extends earlier studies that have shown 
that 7T MRI is feasible and superior in many instances to 3T MRI and that we are at the 
doorstep of its routine use in both healthy subjects and diverse clinical populations, 
eventually combined with other data modalities.
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